Hello! If you're looking for high-quality genericmedications, fast delivery and excellent customer service, ourstore is the right choice for you. With over 20 years of onlineexperience, we guarantee safe, effective products that are alwaysin stock. Delivery within 48 hours, free shipping from $200, and 100% money-back guarantee if your order doesn't arrive on time.

👉 Order now at BestCheapPills and discover exclusive discounts for registeredcustomers!

Cancer has emerged as one of the most pressing health challenges of our time, and India finds itself at the centre of a growing battle against this devastating disease. With new cases rising year after year and healthcare infrastructure often struggling to keep pace. Behind the statistics, however, lie stories of human resilience, despair, and the pressing need for a healthcare model that goes beyond conventional boundaries. It is in this context that a recent recommendation by a Parliamentary Committee has sparked a fresh conversation that dares to ask whether India’s traditional systems of healing, rooted in Ayurveda, Homeopathy, Unani, and Siddha, can be meaningfully integrated with mainstream oncology to create a more holistic approach to cancer care. The question is provocative, but the answers may hold the key to reshaping the way a nation addresses its cancer burden.

The Rajya Sabha’s Committee on Petitions, chaired by Narain Dass Gupta, presented its 163rd report urging the government to expand the institutional footprint of AYUSH-based healthcare services across the country. The idea is not to replace conventional oncology but to promote integrative oncology, where patients can benefit from both advanced allopathic treatment and therapeutic options derived from India’s traditional knowledge systems. Such a move, the committee suggested, would require setting up dedicated AYUSH cancer care institutions in every state and Union Territory, modeled after the All India Institute of Ayurveda in New Delhi. By doing so, India could offer its citizens a wider canvas of therapeutic choices, encouraging a synergy of ancient and modern approaches in one of the most complex areas of healthcare.

At first glance, the idea may seem ambitious, perhaps even idealistic. Yet the logic behind it is compelling. Ayurveda, Siddha, Unani, and Homeopathy have been practiced for centuries in India, forming a vital part of the nation’s cultural and medical heritage. These systems emphasize balance, prevention, and natural therapies, which resonate strongly with patients searching for options beyond chemotherapy, radiation, and surgery. In the case of cancer, where side effects of conventional treatments often take a heavy toll, patients frequently turn to alternative therapies for relief, comfort, and a sense of agency. What the Committee’s recommendation seeks to do is formalize and regulate this space, ensuring that patients who choose integrative care are not left vulnerable to unscientific or unverified practices but are guided within the safety of credible, evidence-backed institutions.

The Ministry of AYUSH has already reported advancements in cancer-related research within these traditional systems. Herbal formulations, dietary interventions, yoga, and holistic lifestyle modifications are being studied for their potential role in prevention, symptom management, and even supportive therapy alongside modern oncology. While these cannot yet claim to cure cancer, their ability to enhance quality of life, reduce treatment-related distress, and strengthen resilience cannot be dismissed. Establishing dedicated AYUSH cancer institutions could provide the structured environment needed to test, refine, and validate such therapies, allowing patients to benefit from integrative approaches without fear of quackery.

But the conversation does not stop at integrative oncology. The Committee went further to recommend that cancer be declared a notifiable disease across all states and Union Territories. This suggestion is as bold as it is overdue. At present, cancer data in India is largely derived from the National Cancer Registry Programme, which covers only around 18 percent of the population. Such limited coverage is woefully inadequate for a country of India’s size, where regional variations in lifestyle, environment, and genetics mean that cancer trends differ widely across states. Declaring cancer as a notifiable disease would compel hospitals, clinics, and practitioners to systematically report cases, creating a real-time national database. This would not only strengthen surveillance but also enable evidence-based policymaking, rational resource allocation, and targeted interventions.

Today, India fights cancer with one hand tied behind its back, relying on fragmented data and partial information. Policymakers often lack the full picture when designing infrastructure or distributing resources. If cancer were made notifiable, the government could track emerging hotspots, identify high-burden regions, and plan accordingly. It could also ensure that underserved rural areas, where access to cancer care remains minimal, are not overlooked in favor of metropolitan centers. The Committee’s suggestion aligns with the urgent need to view cancer not just as a medical condition but as a public health crisis demanding systematic and transparent reporting.

Alongside institutional reform and surveillance, the report also touched upon the role of corporate social responsibility (CSR) in building a robust cancer care ecosystem. The committee pointed out that while banks, public sector units, and large corporations do contribute significantly under CSR mandates, these efforts are often compliance-driven and concentrated in areas close to their business operations. This leaves large swathes of the country underserved. By recommending that a defined share of CSR funds be earmarked for cancer care, the Committee seeks to shift this paradigm towards a needs-based, outcome-driven model. Imagine the impact if corporates joined hands with the government to set up diagnostic centers, radiotherapy units, and palliative care facilities in rural and semi-urban regions where patients currently travel hundreds of kilometers for treatment. Such an approach could bridge critical gaps in accessibility and bring cancer care within the reach of millions who otherwise remain excluded.

Equally important is the focus on affordability. Cancer is one of the most financially devastating illnesses for Indian families, often pushing households into debt or bankruptcy. Patient Assistance Programmes, such as the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, have already demonstrated their value by making low-cost medicines available to the economically vulnerable. Expanding such initiatives, the Committee suggested, could significantly ease the burden on patients. Moreover, pharmaceutical companies, which already run limited patient support programmes, could be encouraged to expand their reach, particularly in rural and underserved regions. But assistance should not stop at providing medicines. Patients must also be educated about available treatment methodologies, guided through government schemes, and supported in adhering to their treatment plans. Awareness is as critical as affordability, for many patients drop out of treatment simply because they are overwhelmed by complexity and cost.

What emerges from the Committee’s report is a vision of cancer care that is integrated, inclusive, and intelligent. It recognizes that India cannot fight cancer with isolated measures but must weave together traditional knowledge, modern science, data-driven policy, corporate responsibility, and patient-centric initiatives into a unified strategy. This vision is provocative because it challenges entrenched silos of allopathy versus AYUSH, the silo of government versus corporates, the silo of treatment versus prevention. By proposing integrative oncology, national notification, CSR alignment, and expanded patient support, it dares to reimagine cancer care as a collective responsibility and a national priority.

Skeptics will, of course, raise questions. Can traditional systems of medicine truly complement oncology, or will they dilute scientific rigor? Will declaring cancer notifiable add bureaucratic burdens to an already strained healthcare system? Can CSR contributions be effectively monitored to prevent misuse? These are valid concerns, but they cannot be reasons to shy away from bold reform. Every transformative step begins with discomfort, and India’s cancer crisis demands nothing less than transformation. The reality is that millions of new cases each year, limited infrastructure, crushing costs, and patients caught in the crossfire of hope and despair. The status quo is no longer an option.

The provocative promise of integrative oncology is not that Ayurveda or Siddha will replace chemotherapy, but that patients will finally receive care that acknowledges their physical, emotional, and cultural needs. Declaring cancer notifiable is not about red tape but about building a data foundation strong enough to guide future policy. Redirecting CSR funds is not about penalizing corporates but about channeling national wealth into national health. And patient assistance is not charity; it is justice for those whose lives are already upended by disease.

As India stands at this critical juncture, the choices made now will echo for decades. If AYUSH institutions dedicated to cancer care rise across the country, if cancer is declared a notifiable disease, if CSR funds create diagnostic and palliative centers in villages, and if affordable medicines reach every patient, then a new era of cancer care may truly begin. One where tradition and modernity coexist, where data drives policy, where corporates partner with government, and where patients are at the heart of the system.

Cancer has long been described as a disease that tests not just the human body but the spirit. Perhaps it also tests the spirit of nations and their ability to innovate, adapt, and protect their people. India now has an opportunity to show that its response to cancer will not be passive but bold, integrated, and visionary. Ancient wisdom and modern medicine may seem like unlikely allies, but in the fight against cancer, their partnership could be the lifeline that millions are waiting for.